Table 3 Primary and Secondary Outcome
|  | ACB+ SHAM (n = 35) | ACB+ IPACK (n = 35) | P value |
|---|---|---|---|
Primary Outcome | |||
 Opioids Consumption (mg OME) | 120 (84–135) | 120 (75–135) | 0.835 |
Secondary Outcome | |||
 The overall VAS at rest, 4 h | 3 (3–4) | 3 (2–3) | 0.013 |
 The overall VAS at rest, 8 h | 3 (2–4) | 2 (2–3) | 0.032 |
 The overall VAS at rest, 24 h | 3 (2–4) | 2 (2–3) | 0.060 |
 The overall VAS at rest, 48 h | 2 (1–3) | 2 (1–2) | 0.079 |
 The overall VAS at rest, 72 h | 2 (1–2) | 2 (1–2) | 0.103 |
 The overall VAS during active flexion, 4 h | 4 (4–5) | 3 (3–4) | 0.001 |
 The overall VAS during active flexion, 8 h | 4 (3–5) | 3 (2–4) | 0.000 |
 The overall VAS during active flexion, 24 h | 3 (2–4) | 2 (2–3) | 0.001 |
 The overall VAS during active flexion, 48 h | 3 (2–3) | 2 (2–3) | 0.086 |
 The overall VAS during active flexion, 72 h | 3 (2–3) | 2 (2–3) | 0.714 |
Rang of Motion (°) | |||
 POD 1 | 53.83 ± 5.86 | 59.11 ± 3.90 | 0.000 |
 POD 2 | 67.20 ± 5.89 | 67.09 ± 5.57 | 0.934 |
 POD 3 | 97.00 ± 3.94 | 97.80 ± 5.58 | 0.504 |
Ambulation Distance (feet) | |||
 POD 1 | 40.83 ± 6.65 | 44.60 ± 4.87 | 0.009 |
 POD 2 | 66.49 ± 4.22 | 68.46 ± 4.85 | 0.074 |
 POD 3 | 96.26 ± 4.95 | 96.48 ± 3.59 | 0.826 |
 Satisfaction for pain management | 8 (7–9) | 9 (8–9) | 0.024 |